Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Unlike existing therapies that target one or two hormonal pathways, Retatrutide is a triple agonist , simultaneously activating three key receptors: GLP-1 (Glucagon-Like Peptide-1) Receptor : Enhances insulin secretion, suppresses appetite, and slows gastric emptying
Compounded semaglutide is typically injected once weekly, the same schedule as brand-name Ozempic and Wegovy
Dulaglutide (Trulicity): Primarily used to manage blood sugar levels in type 2 diabetes, dulaglutide also offers potential benefits for weight management
Quebec company banned from selling unauthorized peptides: Health Canada Posted July 29, 2026 4:13 pm
Frequently Asked Questions TRIUMPH-1 (May 21, 2026) showed retatrutide achieved 28.3% average weight loss at 80 weeks in 2,339 adults without diabetes
Making the decision: which side effect profile fits your situation After reviewing all this data, the question remains
